Ryo Tsumura

Title: Ryo Tsumura: Innovator in Cancer Treatment

Introduction

Ryo Tsumura is a prominent inventor based in Chiba, Japan, known for his significant contributions to cancer treatment through innovative antibody technologies. With a total of two patents to his name, Tsumura's work focuses on developing therapeutic agents that target solid tumors.

Latest Patents

Tsumura's latest patents include an antibody beneficial for the treatment of solid tumors, an antibody-drug conjugate, and a cancer drug that incorporates these innovations. The first patent presents an antibody that binds to tissue factor or an antigen-binding fragment thereof, characterized by a dissociation rate constant (kd) of 5×10 or more and an association rate constant (Ka) of 1×10 or more. The second patent discloses monoclonal antibodies against human and mouse tissue factor, along with pharmaceutical compositions and drug delivery systems that utilize these antibodies. Therapeutic methods employing these innovations are also outlined in his patents.

Career Highlights

Throughout his career, Tsumura has worked with esteemed institutions such as the National Cancer Center and The University of Tokyo. His research has significantly advanced the field of oncology, particularly in the development of targeted therapies for cancer patients.

Collaborations

Tsumura has collaborated with notable colleagues, including Yasuhiro Matsumura and Masahiro Yasunaga, contributing to the advancement of cancer treatment methodologies.

Conclusion

Ryo Tsumura's innovative work in antibody development represents a crucial step forward in cancer therapy. His patents and collaborations highlight his commitment to improving treatment options for patients with solid tumors.